Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma.

Autor: Hose, Dirk1 (AUTHOR) dirk.hose@vub.be, Ray, Seemun2 (AUTHOR), Rößler, Sina3 (AUTHOR), Thormann, Ulrich2 (AUTHOR), Schnettler, Reinhard4 (AUTHOR), de Veirman, Kim1 (AUTHOR), El Khassawna, Thaqif2 (AUTHOR), Heiss, Christian2 (AUTHOR), Hild, Anne5 (AUTHOR), Zahner, Daniel4 (AUTHOR), Alagboso, Francisca2 (AUTHOR), Henss, Anja6 (AUTHOR), Beck, Susanne1 (AUTHOR), Emde-Rajaratnam, Martina1 (AUTHOR), Burhenne, Jürgen7 (AUTHOR), Bamberger, Juliane8 (AUTHOR), Menu, Eline1 (AUTHOR), de Bruyne, Elke1 (AUTHOR), Gelinsky, Michael9 (AUTHOR), Kampschulte, Marian8 (AUTHOR)
Zdroj: Journal of Hematology & Oncology. 12/18/2024, Vol. 17 Issue 1, p1-20. 20p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje